MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection

Sarah AE  Rupprechter; Derek J Sloan; Wilna Oosthuyzen; Till T Bachmann; Adam T Hill; Kevin Dhaliwal; Kate Templeton; Joshua  Matovu; Christine  Sekaggya-Wiltshire; James W Dear

doi:10.1111/bcp.14736

MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection

Sarah AE Rupprechter, Derek J Sloan, Wilna Oosthuyzen, Till T Bachmann, Adam T Hill, Kevin Dhaliwal, Kate Templeton, Joshua Matovu, Christine Sekaggya-Wiltshire, James W Dear

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Clinical Pharmacology
Early online date	11 Jan 2021
DOIs	https://doi.org/10.1111/bcp.14736
Publication status	E-pub ahead of print - 11 Jan 2021

Access to Document

10.1111/bcp.14736Licence: Creative Commons: Attribution (CC-BY)

miR122 and K18 in TB V2 cleanAccepted author manuscript, 1 MB

Cite this

Rupprechter, S. AE., Sloan, D. J., Oosthuyzen, W., Bachmann, T. T., Hill, A. T., Dhaliwal, K., Templeton, K., Matovu, J., Sekaggya-Wiltshire, C., & Dear, J. W. (2021). MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1111/bcp.14736

@article{722a7296656b4ec89c89f9776ebd15c1,

title = "MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection",

author = "Rupprechter, {Sarah AE} and Sloan, {Derek J} and Wilna Oosthuyzen and Bachmann, {Till T} and Hill, {Adam T} and Kevin Dhaliwal and Kate Templeton and Joshua Matovu and Christine Sekaggya-Wiltshire and Dear, {James W}",

year = "2021",

month = jan,

day = "11",

doi = "10.1111/bcp.14736",

language = "English",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

}

Rupprechter, SAE, Sloan, DJ, Oosthuyzen, W, Bachmann, TT, Hill, AT, Dhaliwal, K, Templeton, K, Matovu, J, Sekaggya-Wiltshire, C & Dear, JW 2021, 'MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14736

TY - JOUR

T1 - MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection

AU - Rupprechter, Sarah AE

AU - Sloan, Derek J

AU - Oosthuyzen, Wilna

AU - Bachmann, Till T

AU - Hill, Adam T

AU - Dhaliwal, Kevin

AU - Templeton, Kate

AU - Matovu, Joshua

AU - Sekaggya-Wiltshire, Christine

AU - Dear, James W

PY - 2021/1/11

Y1 - 2021/1/11

U2 - 10.1111/bcp.14736

DO - 10.1111/bcp.14736

M3 - Article

SN - 0306-5251

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

ER -